Insider Transactions in Q2 2025 at Recursion Pharmaceuticals, Inc. (RXRX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2025
|
Zavain Dar Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,745
+2.42%
|
-
|
|
Apr 01
2025
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,268
+2.77%
|
-
|
|
Apr 01
2025
|
Ben R Taylor Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,571
-3.06%
|
$132,855
$5.09 P/Share
|